NCT06984484 - Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease | Biotech Hunter

Enrollment

208

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DEVICE

Afluxin®

Afluxin® stick pack is an oral suspension to be taken without any liquid 3 times a day after breakfast, lunch and before going to bed, for 7 days.

DRUG

Placebo

Inactive control stick pack is an oral suspension to be taken without any liquid 3 times a day after breakfast, lunch and before going to bed, for 7 days.

Trial Locations (6)

10126

NOT_YET_RECRUITING

A.O.U. Città della Salute e della Scienza di Torino, Torino

16132

RECRUITING

IRCCS Policlinico San Martino, Genova

20089

NOT_YET_RECRUITING

Humanitas Research Hospital, Rozzano (MI)

20122

RECRUITING

IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan

35128

RECRUITING

Azienda Ospedale Università Padova, Padua

80131

RECRUITING

AOU Federico II di Napoli, Napoli

All Listed Sponsors

lead

Devintec Sagl

INDUSTRY